Product
Angiotensin-converting enzyme inhibitors + angiotensin II receptor blocker + angiotensin receptor-neprilysin inhibitor
1 clinical trial
2 indications
Indication
Mitral Valve RegurgitationIndication
Congestive Heart FailureClinical trial
Development and Validation of the Prediction Model for Functional Mitral Regurgitation Regression in Heart Failure Patients Taking Guideline-directed Medical TherapyStatus: Recruiting, Estimated PCD: 2025-06-01